Share this Page:
« Back to Glossary Index
Clinical trial participants do not know which treatment they are receiving.
« Back to Glossary IndexBlinded
9 Mar 2016
Kidney cancer news
30 Nov 2023
Belzutifan for advanced kidney cancer: long-term follow-up
29 Nov 2023
NICE Annual Conference
28 Nov 2023
Longer better lives: A manifesto for cancer research and care
27 Nov 2023
ESMO 2023: New online educational programme for kidney cancer nurses
23 Nov 2023
Cancer Patient Experience Survey 2023
16 Nov 2023
Artificial intelligence has potential to improve urology services
13 Nov 2023
New treatment, zanzalintinib, for advanced kidney cancer
13 Nov 2023
Treatment of translocation kidney cancer
10 Nov 2023
Real world treatment of advanced kidney cancer
1 Nov 2023
AI tools to speed up cancer diagnosis
1 Nov 2023
Community Diagnostic Centres to speed up lifesaving checks
1 Nov 2023
Carers' Rights Day
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo sunitinib Sutent cabozantinib progression-free survival NHS England biomarkers ipilimumab Cabometyx pembrolizumab COVID-19 axitinib cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus Yervoy risk factors Keytruda metastases adjuvant therapy targeted therapy biological markers papillary RCC everolimus kidney cancer Afinitor cancer outcomes first-line treatment ASCO NICEArchives
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
